| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,800 |
4,220 |
$467K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,792 |
4,304 |
$321K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
753 |
678 |
$72K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,293 |
2,119 |
$66K |
| G9001 |
Coordinated care fee, initial rate |
1,221 |
1,221 |
$47K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
469 |
458 |
$44K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,835 |
3,320 |
$28K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
610 |
569 |
$25K |
| 90461 |
|
506 |
469 |
$18K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
185 |
172 |
$16K |
| 99215 |
Prolong outpt/office vis |
107 |
86 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
629 |
299 |
$10K |
| 96116 |
|
253 |
228 |
$9K |
| 96127 |
|
1,968 |
1,734 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
322 |
306 |
$5K |
| 96160 |
|
2,133 |
1,806 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
27 |
$3K |
| 96156 |
|
419 |
353 |
$2K |
| 94760 |
|
1,032 |
909 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
51 |
43 |
$609.47 |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
13 |
13 |
$442.00 |
| 81025 |
|
28 |
24 |
$213.21 |
| 99406 |
|
56 |
55 |
$180.08 |
| 99401 |
|
72 |
71 |
$159.46 |
| 81002 |
|
14 |
12 |
$48.72 |
| 97802 |
|
399 |
353 |
$24.74 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
15 |
$3.12 |
| 90686 |
|
866 |
814 |
$0.02 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
86 |
83 |
$0.00 |
| 3085F |
|
1,000 |
820 |
$0.00 |
| 90672 |
|
29 |
27 |
$0.00 |
| S9470 |
Nutritional counseling, dietitian visit |
171 |
160 |
$0.00 |
| 3725F |
|
40 |
30 |
$0.00 |
| G9395 |
Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five |
65 |
54 |
$0.00 |
| 2014F |
|
14 |
14 |
$0.00 |
| 90734 |
|
53 |
49 |
$0.00 |
| 97803 |
|
16 |
16 |
$0.00 |
| G9393 |
Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five |
250 |
223 |
$0.00 |
| 1000F |
|
410 |
375 |
$0.00 |
| 90845 |
|
239 |
200 |
$0.00 |
| 90651 |
|
26 |
26 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
255 |
219 |
$0.00 |
| 90619 |
|
13 |
13 |
$0.00 |